 | Up a level |
Giger, U.; Ouaissi, M.; Hsu Schmitz, S.-F.; Krähenbühl, S.; Krähenbühl, L. (2011). Risk factors for bile duct injury during laparoscopic cholecystectomy. British journal of surgery, 98(3), pp. 391-396. Bristol, UK: John Wright & Sons 10.1002/bjs.7335
Ghielmini, M.; Rufibach, K.; Salles, G.; Leoncini-Franscini, L.; Léger-Falandry, C.; Cogliatti, S.; Fey, M.; Martinelli, G.; Stahel, R.; Lohri, A.; Ketterer, N.; Wernli, M.; Cerny, T.; Hsu Schmitz, S.-F. (2005). Single agent rituximab in patients with follicular or mantle cell lymphoma: clinical and biological factors that are predictive of response and event-free survival as well as the effect of rituximab on the immune system: a study of the Swiss Group for Clinical Cancer Research (SAKK). Annals of oncology, 16(10), pp. 1675-1682. Oxford University Press 10.1093/annonc/mdi320
Cerny, T.; Leyvraz, S.; Von Briel, T.; Küpfer, A.; Schaad, R.; Hsu Schmitz, S.-F.; Honegger, P.; Sessa, C.; Brunner, J.; Boddy, A. V. (1999). Saturable metabolism of continuous high-dose ifosfamide with Mesna and GM-CSF: A pharmacokinetic study in advanced sarcoma patients. Annals of oncology, 10(9), pp. 1087-1094. Oxford University Press 10.1023/A:1008386000547
Betticher, D. C.; Ratschiller, D.; Hsu Schmitz, S.-F.; Von Rohr, A.; Hess, U.; Zulian, G.; Wernli, M.; Tichelli, A.; Tobler, A.; Fey, M. F.; Cerny, T. (1998). Reduced dose of subcutaneous cladribine induces identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemia. Annals of oncology, 9(7), pp. 721-726. Oxford University Press 10.1023/A:1008273131598
